v3.26.1
(Loss) Income Per Share (Tables)
6 Months Ended
Jun. 30, 2026
Earnings Per Share [Abstract]  
Schedule of Computation of Basic and Diluted (Loss) Earnings Per Share

The following table shows the computation of basic and diluted (loss) earnings per share for the three months ended June 30, 2026 (in thousands, except share and per share amounts):

 

 

 

Three Months Ended June 30,

 

 

2026

 

 

2025

 

Numerator:

 

 

 

 

 

 

Net (Loss) Income Attributable to Common Stock Holders

 

$

(1,337

)

 

$

608

 

Denominator:

 

 

 

 

 

 

Weighted average common shares outstanding - Basic

 

 

66,888,860

 

 

 

64,043,388

 

Dilutive effect of stock options, RSUs and warrants

 

 

 

 

 

7,217,934

 

Weighted average common shares outstanding - Diluted

 

 

66,888,860

 

 

 

71,261,322

 

Basic (loss) earnings per share

 

$

(0.02

)

 

$

0.01

 

Diluted (loss) earnings per share (1)

 

$

(0.02

)

 

$

0.01

 

 

The following table shows the computation of basic and diluted earnings per share for the six months ended June 30, 2026 and 2025 (in thousands, except share and per share amounts):

 

 

 

Six Months Ended June 30,

 

 

2026

 

 

2025

 

Numerator:

 

 

 

 

 

 

Net Income Attributable to Common Stock Holders

 

$

1,354

 

 

$

762

 

Denominator:

 

 

 

 

 

 

Weighted average common shares outstanding - Basic

 

 

66,483,508

 

 

 

63,132,541

 

Dilutive effect of stock options, RSUs and warrants

 

 

4,442,538

 

 

 

7,217,934

 

Weighted average common shares outstanding - Diluted

 

 

70,926,046

 

 

 

70,350,475

 

Basic earnings per share

 

$

0.02

 

 

$

0.01

 

Diluted earnings per share (1)

 

$

0.02

 

 

$

0.01

 

 

 

(1) There were 10,195,451 warrants and 4,442,538 RSUs outstanding at June 30, 2026, and there were 17,732,764 warrants and 7,217,934 RSUs outstanding at June 30, 2025. The Company excluded the RSUs and warrants from the calculation of diluted EPS for the three month period ended June 30, 2026, and excluded the warrants from the calculation of diluted EPS for the three month period ended June 30, 2025 and for the six month periods ended June 30, 2026 and 2025, as inclusion would have an anti-dilutive effect.